Blastic plasmocytoid dendritic cell neoplasm: a diagnostic challenge

Authors

DOI:

https://doi.org/10.29176/2590843X.1783

Keywords:

CD56 antigen, Dendritic cells, Leukemia myeloid, Neoplasms, Plasmacytoid dendritic cells

Abstract

Blastic plasmacytoid dendritic cell neoplasm is a very rare tumor that represents less than 1% of all hematopoietic malignancies; with high skin involvement and risk of leukemic dissemination, as well as aggressive behavior with a median survival of 14 months and a relapse rate of 17-33%. The diagnosis must be determined histologically and immunophenotypically by checking the positivity mainly of CD4 and CD56, in the absence of other specific lineage markers. This tumor has been associated with a history of myelodysplastic syndrome and myeloproliferative neoplasms; however, to date it is the first reported case of the association of a patient with pharmacological immunosuppression and this type of tumor as a possible risk factor.

Author Biographies

Katty Camila Anaya Reyes, Universidad Autonoma de Bucaramanga

Residente de Dermatología, Universidad Autónoma de Bucaramanga.

Español Español, Foscal Internacional, Floridablanca, Santander, Colombia

Dermatóloga, Universidad Autónoma de Bucaramanga. Foscal Internacional, Floridablanca, Santander.

 

Español Español, Universidad Autónoma de México

Médico especialista en Hematopatología, Universidad Autónoma de México.

References

Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174:188-202. https://doi.org/10.1111/bjh.14146

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/ Dendritic Neoplasms. Leukemia. 2022;36:1703-1719. Doi: https://doi.org/10.1038/s41375-022-01613-1

Blastic Plasmacytoid Dendritic Cell Neoplasm. Curr Hematol Malig Rep. 2018 Dec;13(6):477-483. https://doi.org/10.1007/s11899-018-0489-z.

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects. Cancers. 2019 abril;11(5):595. https://doi.org/10.3390/cancers11050595

Blastic Plasmacytoid Dendritic Cell NeoplasmeCurrent Insights. Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):545-554. https://doi.org/10.1016/j.clml.2019.06.002.

Leucemia de células dendríticas plasmocitoides. Rev Hematol Mex. 2020 enero-marzo; 21(1): 61-67. Doi: https://doi.org/10.24245/rev_hematol.v21i1.3886

Blastic Plasmacytoid Dendritic Cell Neoplasm The Dermatologist’s Perspective. Hematol Oncol Clin North Am. 2020;34:501–509. https://doi.org/10.1016/j.hoc.2020.01.001.

How to Cite

1.
Anaya Reyes KC, Español E, Español E. Blastic plasmocytoid dendritic cell neoplasm: a diagnostic challenge. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2025 Apr. 29 [cited 2026 Mar. 21];33(2). Available from: https://revistaasocoldermaorgco.biteca.online/index.php/asocolderma/article/view/1783

Downloads

Download data is not yet available.

Published

2025-04-29

How to Cite

1.
Anaya Reyes KC, Español E, Español E. Blastic plasmocytoid dendritic cell neoplasm: a diagnostic challenge. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 2025 Apr. 29 [cited 2026 Mar. 21];33(2). Available from: https://revistaasocoldermaorgco.biteca.online/index.php/asocolderma/article/view/1783

Issue

Section

Case Report
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo

Some similar items: